Editorial: Safety Pharmacology – Risk Assessment QT Interval Prolongation and Beyond-Reference-Cited by-同舟云学术

Editorial: Safety Pharmacology – Risk Assessment QT Interval Prolongation and Beyond

Published:2018-06-08 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Grandi Eleonora,Morotti Stefano,Pueyo Esther,Rodriguez Blanca

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

American Heart Association

Heart Rhythm Society

Ministerio de Economía y Competitividad

European Research Council

Wellcome Trust

National Centre for the Replacement, Refinement and Reduction of Animals in Research

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference29 articles.

1. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes;Antzelevitch;Heart Rhythm,2005

2. Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity;Ellinwood;Chaos,2017

3. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice;Food and Drug Administration;Fed. Regist.,2005

4. Population of computational rabbit-specific ventricular action potential models for investigating sources of variability in cellular repolarisation;Gemmell;PLoS ONE,2014

5. Evolution of strategies to improve preclinical cardiac safety testing;Gintant;Nat. Rev. Drug Discov.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Verification, Validation and Sensitivity Studies of Computational Models used in Toxicology Assessment;Computational Toxicology for Drug Safety and a Sustainable Environment;2023-12-17

2. In Silico Trial Approach for Biomedical Products: A Regulatory Perspective;Combinatorial Chemistry & High Throughput Screening;2022-10

3. The virtual assay software for human in silico drug trials to augment drug cardiac testing;Journal of Computational Science;2021-05

4. In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products;Methods;2021-01

5. Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells;Regulatory Toxicology and Pharmacology;2020-10